Advertisement

Prediction model for testis histology in men with non-obstructive azoospermia: evidence for a limited predictive role of serum follicle-stimulating hormone

  • Ettore Caroppo
  • Elisabetta M. Colpi
  • Giuseppe D’Amato
  • Giacomo Gazzano
  • Giovanni M. Colpi
Reproductive Physiology and Disease

Abstract

Purpose

The present prediction model was intended to verify whether serum FSH level could be predictive of testis histology in patients with non-obstructive azoospermia (NOA).

Methods

We evaluated two datasets of patients with NOA: the first (San Paolo dataset) comprising 558 patients, 18–63 years old, the second (Procrea dataset) composed by 143 patients, 26–62 years old; bot datasets were combined to obtain a validation set. Multinomial logistic regression was first run with serum FSH and testis volume as independent predictors of testis histology, then, the correctly classified histological subcategories were set as outcome variables of a prediction model in both development and validation sets.

Results

Multinomial logistic regression showed that FSH was a significant predictor of testis histology in 58% of cases, although it was unable to correctly classify cases with focal SCO or maturation arrest (MA). A prediction model was then run with hypospermatogenesis (HYPO) and Sertoli-only syndrome (SCO) as outcome variables of a binary logistic regression. FSH significantly predicted both HYPO and SCO, with a sensitivity of 40.9 and 80.7 and a specificity of 84.3 and 46.8 respectively. The model showed a fair discriminative ability (ROC AUC 0.705 and 0.709 respectively) and was adequately calibrated.

Conclusions

Supported by a robust statistical analysis, we conclude that serum FSH level cannot be considered a prognostic marker of spermatogenic dysfunction in patients with NOA

Keywords

FSH Testis histology Testis volume Non-obstructive azoospermia Prediction model 

Notes

Compliance with ethical standards

Conflict of interest

Caroppo E. reports personal fees from Ferring Pharmaceutical, outside of the submitted work. Colpi EM, D’Amato G, Gazzano G, and Colpi GM has nothing to disclose.

Ethical approval

The present study did not involve human or animal participants, being a retrospective analysis of de-identified data from two separate databases. For this type of study formal consent is not required.

IRB approval

This is a secondary analysis of already published data. For both datasets, local IRB approval for the retrospective analysis of de-identified data had been obtained before conducting the original research. The present study was performed on de-identified, non-coded data.

Supplementary material

10815_2019_1613_MOESM1_ESM.docx (19 kb)
ESM 1 (DOCX 19 kb)

References

  1. 1.
    Practice Committee of the American Society for Reproductive Medicine in collaboration with the Society for Male Reproduction and Urology. Evaluation of the azoospermic male: a committee opinion. Fertil Steril. 2018;109:777–82.CrossRefGoogle Scholar
  2. 2.
    Schoor RA, Elhanbly S, Niederberger CS, Ross LS. The role of testicular biopsy in the modern management of male infertility. J Urol. 2002;167:197–200.CrossRefGoogle Scholar
  3. 3.
    Ramasamy R, Lin K, Veeck G, Rosenwaks Z, Palermo GD, Schlegel PN. High serum FSH levels in men with nonobstructive azoospermia does not affect success of microdissection testicular sperm extraction. Fertil Steril. 2009;92:590–3.CrossRefGoogle Scholar
  4. 4.
    Li H, Chen LP, Yang J, Li MC, Chen RB, Lan RZ, et al. Predictive value of FSH, testicular volume, and histopathological findings for the sperm retrieval rate of microdissection TESE in nonobstructive azoospermia: a metanalysis. Asian J Androl. 2018;20:30–6.CrossRefGoogle Scholar
  5. 5.
    Bergman M, Behre HM, Nieschlag E. Serum FSH and testicular morphology in male infertility. Clin Endocrinol. 1994;40:133–6.CrossRefGoogle Scholar
  6. 6.
    Von Eckardstein S, Simoni M, Bergmann M, Weinbauer GF, Gassner P, Schepers AG, et al. Serum inhibin B in combination with serum follicle-stimulating hormone is a more sensitive marker than FSH alone for impaired spermatogenesis in men, but cannot predict the presence of sperm in testicular tissue samples. J Clin Endocrinol Metab. 1999;84:2496–50.Google Scholar
  7. 7.
    Caroppo E, Colpi EM, Castiglioni M, Gazzano G, Vaccalluzzo L, D’Amato G, et al. Role of FSH level, testicular volume and histology in choosing the appropriate surgical technique of sperm retrievals in patients with non-obstructive azoospermia. Hum Reprod. 2015;30:i132–3.Google Scholar
  8. 8.
    Caroppo E, Colpi EM, Gazzano G, Vaccalluzzo L, Scroppo FI, D’Amato G, et al. Testicular histology may predict the successful sperm retrieval in patients with non-obstructive azoospermia undergoing conventional TESE: a diagnostic accuracy study. J Assist Reprod Genet. 2017;34:149–54.CrossRefGoogle Scholar
  9. 9.
    Caroppo E, Colpi EM, Gazzano G, Vaccalluzzo L, Piatti E, D’Amato G, et al. The seminiferous tubule caliber pattern as evaluated at high magnification during microdissection testicular sperm extraction predicts sperm retrieval in patients with non-obstructive azoospermia. Andrology. 2019;7:8–14.CrossRefGoogle Scholar
  10. 10.
    Alba AC, Agoritsas T, Walsh M, Hanna S, Iorio A, Devereaux PJ, et al. Discrimination and calibration of clinical prediction models users’ guide to the medical literature. JAMA. 2017;318:1377–84.CrossRefGoogle Scholar
  11. 11.
    Moons KGM, Altman DG, Reitsma JB, Ioannidis JPA, Macaskill P, Steyeberg EW, et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med. 2015;162:W1–W73.CrossRefGoogle Scholar
  12. 12.
    Flannigan R, Bach PV, Schlegel PN. Microdissection testicular sperm extraction. Transl Androl Urol. 2017;6:745–52.CrossRefGoogle Scholar
  13. 13.
    De Kretser DM, Burger HG, Hudson B. The relationship between germinal cells and serum FSH levels in males with infertility. J Clin Endocrinol Metab. 1974;38:787–93.CrossRefGoogle Scholar
  14. 14.
    Walczak-Jedrzejowska R, Marchlewska K, Oszukowska E, Filipiak E, Slowikowska-Hilczer J, Kula K. Estradiol and testosterone inhibit rat seminiferous tubule development in a hormone-specific way. Reprod Biol. 2013;13:243–50.CrossRefGoogle Scholar
  15. 15.
    Grunewald S, Glander HJ, Paasch U, Kratzsch J. Age-dependent inhibin B concentration in relation to FSH and semen sample qualities: a study in 2448 men. Reproduction. 2013;145:237–44.CrossRefGoogle Scholar
  16. 16.
    Yang Q, Huang YP, Wang HX, Hu K, Wang YX, Huang YR, et al. Follicle-stimulating hormone as a predictor for sperm retrieval rate in patients with nonobstructive azoospermia: a systematic review and meta-analysis. Asian J Androl. 2015;17:281–4.CrossRefGoogle Scholar
  17. 17.
    Grigorova M, Punab M, Ausmees K, Laan M. FSHB promoter polymorphism within evolutionary conserved element is associated with serum FSH level in men. Hum Reprod. 2008;23:2160–6.CrossRefGoogle Scholar
  18. 18.
    Tamburino L, La Vignera S, Tomaselli V, Condorelli RA, Cannarella R, Mongioì LM, et al. The -29G/A FSH receptor gene polymorphism is associated with higher FSH and LH levels in normozoospermic men. J Assist Reprod Genet. 2017;34:1289–94.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Asl Bari, Department of Maternal and Child HealthReproductive and IVF UnitConversanoItaly
  2. 2.ConversanoItaly
  3. 3.Andrology and IVF UnitClinica San CarloPaderno DugnanoItaly
  4. 4.Division of Anatomic PathologyIstituto Auxologico Italiano IRCCSMilanoItaly
  5. 5.Andrology UnitProcrea InstituteLuganoSwitzerland

Personalised recommendations